Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells

Miyata, 1989, Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells, Biochem. Biophys. Res. Commun., 164, 567, 10.1016/0006-291X(89)91757-9

Miyata, 1990, Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP-38), Biochem. Biophys. Res. Commun., 170, 643, 10.1016/0006-291X(90)92140-U

Mungan, 1991, Effect of pituitary adenylate cyclase activating polypeptide on rat pancreatic exocrine secretion, Peptides, 12, 559, 10.1016/0196-9781(91)90101-T

Raufman, 1991, PACAP-38, a novel peptide from ovine hypothalamus, is a potent modulator of amylase release from dispersed acini from rat pancreas, Regul. Pept., 36, 121, 10.1016/0167-0115(91)90200-Z

Cardell, 1991, Pituitary adenylate cyclase activating peptide (PACAP) in guinea-pig lung: distribution and dilatory effects, Regul. Pept., 36, 379, 10.1016/0167-0115(91)90071-N

Warren, 1991, Pituitary adenylate cyclase-activating polypeptide: a novel, long-lasting, endothelium-independent vasorelaxant, Eur. J. Pharmacol., 197, 131, 10.1016/0014-2999(91)90511-N

Koch, 1992, Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates cyclic AMP formation as well as peptide output of cultured pituitary melanotrophs and AtT-20 corticotrophs, Regul. Pept., 38, 45, 10.1016/0167-0115(92)90071-2

Mungan, 1992, Pituitary adenylate cyclase activating polypeptide-27 (PACAP-27) inhibits pentagastrin-stimulated gastric acid secretion in conscious rats, Regul. Pept., 38, 199, 10.1016/0167-0115(92)90102-Z

Araki, 1992, Relaxant effect of pituitary adenylate cyclase-activating polypeptide on guinea-pig tracheal smooth muscle, Eur. J. Pharmacol., 216, 113, 10.1016/0014-2999(92)90217-R

Buscail, 1990, Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J, FEBS Lett., 262, 77, 10.1016/0014-5793(90)80158-F

Yanaihara, 1981, Dibutyryl cAMP stimulation of production and release of VIP-like immunoreactivity in a human neuroblastoma cell line, Biomed. Res., 2, 728, 10.2220/biomedres.2.728

Hoshino, 1984, Production of VIP- and PHM (human PHI)-related peptides in human neuroblastoma cells, Peptides, 5, 155, 10.1016/0196-9781(84)90199-2

Ogino, 1986, Processing products of VIP/PHM precursor in human neuroblastoma cultured cells, 385

Robberecht, 1992, Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes, Eur. J. Biochem., 207, 239, 10.1111/j.1432-1033.1992.tb17043.x

Deutsch, 1992, The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth, J. Biol. Chem., 287, 5106

Volker, 1985, Radioimmunoassay of cyclic AMP can provide a highly sensitive assay for adenylate cyclase, even at very high ATP concentrations, Anal. Biochem., 144, 347, 10.1016/0003-2697(85)90127-7